Dr. Alper

Dr. Alper

Feb 06, 2018

Group 6 Copy 212
0
    Please wait...

    About This Project

    Pancreatic cancer is the third leading cause of cancer-related death in the US, and expected to become the second leading cause of cancer death by 20201. Pancreatic cancer is frequently not diagnosed until it has metastasized resulting in 5-year survival rate of 8%. We will identify novel tumor markers to detect pancreatic cancer at an early stage.

    1: Pancreatic Cancer Action Network 2016

    More Lab Notes From This Project

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

    Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

    Can Effective Delivery of Curcumin be Used to Suppress Cancer Cell Growth?

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can...

    Do human activities increase antibiotic-resistant disease in Chilean penguins?

    Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...

    Backer Badge Funded